Drugmaker Suven Life Sciences Ltd secured four product patents from Eurasia, Europe, Israel and Macau for its New Chemical Entities. These patents, valid through 2030, cover selective 5-HT compounds being developed to treat cognitive disorders like Alzheimer's, ADHD, Huntington's and Parkinson's diseases. Suven CEO said they are pleased to receive these patents for molecules in the CNS area with high unmet medical need and market potential globally. Oil prices extended their decline on worries over global oversupply and slowing demand growth. Asian markets opened lower on Monday following a slump in US stocks on Friday due to concerns over declining oil prices and China's yuan. Indian shares may open weak, tracking Asian peers and ahead of
The document discusses the Indian pharmaceutical sector facing regulatory hurdles in international markets like the US due to a shortage of drug inspectors. It notes there are around 1,500 inspectors for over 10,000 factories producing pharmaceutical products in India. The sector is facing challenges in markets like the US and EU. It provides technical analysis on Cipla, recommending selling within the range of 623-627, targeting 610. It also recommends buying BHEL within 167-169, targeting 173. It includes updates on US stocks, Asian stocks, and expected opening of Indian shares.
Choice Broking Financial Tips Morning Tea- LUPIN: Buy in the range of 1781-1793 for the Target of 1830 with the SL of 1763
IOC: Buy in the range of 416-419 for the Target of 428 with the SL of 411
- The Left Democratic Front (LDF) government in Kerala is planning to introduce a revised liquor policy based on abstinence that will be different from the previous government's policy which had banned buying and selling of liquor and forced some shops to close.
- The report recommends buying Bharti Airtel in the range of 320-322 for a target of 328 with a stop loss of 317 based on a technical analysis showing the stock has support at 310 and momentum indicators pointing to upside potential.
- Asian stock markets rose after OPEC members agreed to cut oil output, boosting investor risk appetite, with Japan's Nikkei up 0.9% and Indian markets expected to open higher.
Lupin receives tentative approval from the US FDA for its generic version of Pfizer's antibiotic drug Azithromycin. Technical analysis indicates the stock is in an uptrend and recommends buying between 1498-1503 levels. Ashok Leyland reports a 6% decline in total vehicle sales for August 2016 compared to the same period last year. Technical analysis finds the stock is bearish and recommends selling between 83-83.80 levels. US markets were flat as gains in tech offset sluggish factory data and lower oil prices ahead of the key US jobs report on Friday which could influence the Fed's decision on interest rates.
Drugmaker Suven Life Sciences Ltd secured four product patents from Eurasia, Europe, Israel and Macau for its New Chemical Entities. These patents, valid through 2030, cover selective 5-HT compounds being developed to treat cognitive disorders like Alzheimer's, ADHD, Huntington's and Parkinson's diseases. Suven CEO said they are pleased to receive these patents for molecules in the CNS area with high unmet medical need and market potential globally. Oil prices extended their decline on worries over global oversupply and slowing demand growth. Asian markets opened lower on Monday following a slump in US stocks on Friday due to concerns over declining oil prices and China's yuan. Indian shares may open weak, tracking Asian peers and ahead of
The document discusses the Indian pharmaceutical sector facing regulatory hurdles in international markets like the US due to a shortage of drug inspectors. It notes there are around 1,500 inspectors for over 10,000 factories producing pharmaceutical products in India. The sector is facing challenges in markets like the US and EU. It provides technical analysis on Cipla, recommending selling within the range of 623-627, targeting 610. It also recommends buying BHEL within 167-169, targeting 173. It includes updates on US stocks, Asian stocks, and expected opening of Indian shares.
Choice Broking Financial Tips Morning Tea- LUPIN: Buy in the range of 1781-1793 for the Target of 1830 with the SL of 1763
IOC: Buy in the range of 416-419 for the Target of 428 with the SL of 411
- The Left Democratic Front (LDF) government in Kerala is planning to introduce a revised liquor policy based on abstinence that will be different from the previous government's policy which had banned buying and selling of liquor and forced some shops to close.
- The report recommends buying Bharti Airtel in the range of 320-322 for a target of 328 with a stop loss of 317 based on a technical analysis showing the stock has support at 310 and momentum indicators pointing to upside potential.
- Asian stock markets rose after OPEC members agreed to cut oil output, boosting investor risk appetite, with Japan's Nikkei up 0.9% and Indian markets expected to open higher.
Lupin receives tentative approval from the US FDA for its generic version of Pfizer's antibiotic drug Azithromycin. Technical analysis indicates the stock is in an uptrend and recommends buying between 1498-1503 levels. Ashok Leyland reports a 6% decline in total vehicle sales for August 2016 compared to the same period last year. Technical analysis finds the stock is bearish and recommends selling between 83-83.80 levels. US markets were flat as gains in tech offset sluggish factory data and lower oil prices ahead of the key US jobs report on Friday which could influence the Fed's decision on interest rates.
Shasun Pharmaceuticals received US FDA approval to market its pain relief drug Carisoprodol in the US. The approval is for 250mg and 350mg strengths which have annual sales of $38 million. Shasun expects to capture the $16 million market for the 250mg tablets as the first generic player.
Apollo Tyres will acquire the German tyre retail company Reifencom GmbH for €45.6 million. Reifencom has annual turnover of €147 million and a presence in Germany and other European countries. The acquisition will help Apollo improve its distribution network in Europe.
Asian stock markets advanced led by energy and airline stocks tracking the rally on Wall Street where major indices rose over
The document provides a summary of global and Asian stock market performance and recommends two Indian stocks - SNOWMAN and RADICO - for trading. It notes that US stocks slipped on Monday as oil prices dropped, while Asian markets were also negative following sluggish global equities. In India, the equity market is expected to open flat tracking Asian indices. Technical analysis is provided for SNOWMAN and RADICO stocks to recommend buying ranges and price targets.
The document provides a technical analysis of various commodities including gold, silver, copper, and crude oil. It notes that gold and silver prices are expected to move higher in the coming trading sessions based on breakouts from patterns and momentum indicators. Copper prices are also forecasted to rise higher towards 338.50 levels based on a breakout from a pennant pattern. Meanwhile, crude oil prices are expected to fall towards 2930 levels given a breakdown from rising wedge and channel patterns. Pivot levels and trends are provided for various commodities.
Lupin shares surged on Thursday after receiving approval from the US FDA for two new drugs. The approvals are expected to generate $154 million in annual revenue. Analysts say competition for one of the drugs is limited to three other generic players. The drug approvals indicate that previous observations at Lupin's Goa plant, which received an FDA Form 483 in July, are not disruptive.
The Uttar Pradesh Electricity Regulatory Commission is seeking details about a 500 megawatt thermal power plant constructed by BHEL in Sonebhadra district. The plant, which cost over Rs. 7,000 crore, has not been able to run properly since being commissioned 8 years
The document provides a summary of US, Asian, and Indian markets. It notes that declines in energy and financial stocks weighed on the S&P 500, while the Nasdaq reached a record high. In Asian markets, shares opened lower following declines in the Dow and a plunge in oil prices. It also provides short updates on various Indian companies and proposed partnerships. Technical analyses are given for two stocks, GSFC and ADANITRANS, recommending buy ranges and price targets.
The US and Asian stock markets fell this week as investors grappled with uncertainty over the upcoming US presidential election. The S&P 500 and Nasdaq saw their eighth straight day of losses on Thursday. Asian shares also slipped on Friday as anxiety rippled over the potential outcome of the US election. In India, the equity market is expected to open lower tracking declines in Asian indices. Other news mentions the GST tax rates being fixed at 5%, 12%, 18% and 28% and that the new tax structure may help reduce inflation. Several companies including Infratech, Heidelberg, Century Textiles and Dish TV are recommended for trading purposes based on technical analysis.
The document provides a market update from the US, Asian, and Indian equity markets. It discusses that US stocks rose on Tuesday as tech stocks rebounded and energy stocks increased with rising oil prices. Asian shares also rose on Wednesday rebounding from losses as Wall Street rallied. In India, the equity market is expected to open higher tracking gains in Asian indices. It also provides recommendations to buy two Indian stocks, CANBK and BHARATFORG based on technical analysis.
The document discusses several stocks and provides technical analysis and recommendations. It suggests buying Dishman Pharmaceuticals between Rs. 135-136 with a target price of Rs. 139 and stop loss of Rs. 133.50. It also recommends buying Bharti Airtel between Rs. 354-356 with a target of Rs. 363.50 and stop loss of Rs. 350.50. Asia markets opened higher on positive global cues and the Indian market is likely to react positively as well.
The document provides a morning market summary and analysis on March 9th, 2017. It discusses movements in global markets, with US markets dipping as energy stocks declined over 5% on rising inventories. Asian markets were mixed as China inflation data was released. The Indian market is expected to open lower tracking Asian indices. Two stocks, Aegischem and Marksans, are recommended as buy trades. The document also provides corporate actions, result calendar, and disclaimer.
The document provides a daily market update and analysis of specific stocks. It discusses rising costs of iron ore and coking coal affecting steel maker Kalyani Steels. It provides technical analysis of KSL and ALKEM stocks, recommending sell targets. Asian stocks opened lower following declines on Wall Street due to concerns over Deutsche Bank. Bulk deals and an earnings calendar are also included.
Dr. Reddy's Laboratories has signed a commercialization deal with Australian pharmaceutical company Hatchtech for its innovative head lice product called Xeglyze Lotion. As part of the deal, Dr. Reddy's will have exclusive rights to market the product in several territories and will pay Hatchtech upfront and milestone payments totaling up to $60 million.
Rolta India has won an additional $13 million contract to load engineering data and documents into an engineering information system it previously designed and developed for one of the world's largest petrochemical complexes.
The markets traded mixed with the Shanghai Composite down 2.21% while the Nikkei rose 1.32% ahead of the US Federal
- Vedanta's subsidiary TSPL commissioned the third 660 MW unit of its 1980 MW Talwandi Sabo thermal power plant in Punjab. TSPL had signed a PPA with Punjab State Power Corporation for establishing the 1980 MW coal-based commercial power plant.
- Dr. Reddy's launched generic versions of heart drug Nitrostat in the US market. The brand drug had US sales of around $108 million last year.
- Asian shares rebounded after doubts over the likelihood of a US Fed rate hike in September weakened the dollar. The Indian market is expected to open flat to higher tracking Asian indices.
- Vijaya Bank reported a 26% drop in net profit for the fourth quarter ended March 2016 to Rs 71.3 crore due to higher provisioning for worsening asset quality. Provisioning more than doubled to Rs 653.3 crore from Rs 305.5 crore last year.
- Glenmark Pharmaceuticals reported over a 13-fold jump in consolidated net profit to Rs 143.04 crore for the March quarter due to robust sales across all markets including the US, Europe and India. Revenue rose to Rs 2,306.67 crore from Rs 1,775.81 crore in the same period last year.
- US stocks ended mixed with gains in telecom and consumer
1) US and Asian stock markets rose as oil prices increased and Morgan Stanley's earnings boosted financial stocks. The Dow and S&P 500 gained slightly while the Nasdaq was mostly flat.
2) In Asia, stocks advanced due to strong US earnings and higher oil prices near 15-month highs as the final US presidential debate began. Indian markets are expected to open higher tracking Asian gains.
3) Several Indian companies received regulatory approvals or announced plans like acquisitions, issues of bonds, and changes to service offerings. Bulk deals and an results calendar were also included.
The document provides a technical analysis of commodity markets. It finds that gold, silver, copper, and crude oil prices are expected to decline in the near future. Gold is seen moving lower to 29500 levels, silver to 40000 levels, copper to 300 levels, and crude oil to 2975 levels. The analysis cites technical indicators like bearish candlestick patterns, prices trading below moving averages, and diverging momentum signals as reasons for the expected downward price movements. Pivot levels are also provided to identify price support and resistance levels.
FIIs and DIIs have increased their stakes in Crompton Greaves and ONGC in the September 2015 quarter compared to the June 2015 quarter. FIIs increased their stake in Crompton Greaves to 16.7% from 15.73% and DIIs increased their stake to 31.62% from 31.19%. For ONGC, FIIs reduced their stake to 6.43% from 7.23% while DIIs increased their stake to 11.05% from 10.43%. The document provides technical analysis on these stocks, recommending a buy for Crompton Greaves between 177-179 and a sell for ONGC between 263-265.
- Wall Street ended mixed on Wednesday as investors focused on President Trump's struggles to pass healthcare reform through Congress, raising concerns about his ability to enact other pro-growth policies like tax cuts.
- Asian stocks rose on Thursday following Wall Street's rebound, while the US dollar crept up from a four-month low amid ongoing uncertainty around Trump's agenda.
- The document provides recommendations to buy two Indian stocks, JKIL and SCHNEIDER, based on technical analysis showing positive trends and momentum in their share prices.
The Reserve Bank of India kept key policy rates unchanged at 7.75% in line with market expectations. While inflation has eased, the RBI is awaiting more information on the fiscal outlook and evidence that disinflation is sustainable. The RBI reduced the statutory liquidity ratio for banks to improve liquidity and provide more credit availability. India's GDP grew by 6.9% in FY14 according to revised estimates, and is projected to grow 7.4% in FY15. Industrial production growth slowed to 1.7% in December 2014, indicating weaker demand despite recent GDP growth figures.
- Aurobindo Pharma Ltd reported a 39.4% rise in Q4 net profit to Rs. 563 crore and an 18.5% increase in Q4 revenue to Rs. 3,747 crore. For the full year, net profit rose 28.5% and revenue grew 14.6%.
- Technical outlook indicates Aurobindo Pharma stock could rise further after bouncing back from support and sustaining above its 100 day moving average. The analyst recommends buying at Rs. 780-784 with a target price of Rs. 800.
- BASF India inaugurated a new construction chemicals plant in West Bengal and is expected to produce products under its Master Builders Solutions brand
Shasun Pharmaceuticals received US FDA approval to market its pain relief drug Carisoprodol in the US. The approval is for 250mg and 350mg strengths which have annual sales of $38 million. Shasun expects to capture the $16 million market for the 250mg tablets as the first generic player.
Apollo Tyres will acquire the German tyre retail company Reifencom GmbH for €45.6 million. Reifencom has annual turnover of €147 million and a presence in Germany and other European countries. The acquisition will help Apollo improve its distribution network in Europe.
Asian stock markets advanced led by energy and airline stocks tracking the rally on Wall Street where major indices rose over
The document provides a summary of global and Asian stock market performance and recommends two Indian stocks - SNOWMAN and RADICO - for trading. It notes that US stocks slipped on Monday as oil prices dropped, while Asian markets were also negative following sluggish global equities. In India, the equity market is expected to open flat tracking Asian indices. Technical analysis is provided for SNOWMAN and RADICO stocks to recommend buying ranges and price targets.
The document provides a technical analysis of various commodities including gold, silver, copper, and crude oil. It notes that gold and silver prices are expected to move higher in the coming trading sessions based on breakouts from patterns and momentum indicators. Copper prices are also forecasted to rise higher towards 338.50 levels based on a breakout from a pennant pattern. Meanwhile, crude oil prices are expected to fall towards 2930 levels given a breakdown from rising wedge and channel patterns. Pivot levels and trends are provided for various commodities.
Lupin shares surged on Thursday after receiving approval from the US FDA for two new drugs. The approvals are expected to generate $154 million in annual revenue. Analysts say competition for one of the drugs is limited to three other generic players. The drug approvals indicate that previous observations at Lupin's Goa plant, which received an FDA Form 483 in July, are not disruptive.
The Uttar Pradesh Electricity Regulatory Commission is seeking details about a 500 megawatt thermal power plant constructed by BHEL in Sonebhadra district. The plant, which cost over Rs. 7,000 crore, has not been able to run properly since being commissioned 8 years
The document provides a summary of US, Asian, and Indian markets. It notes that declines in energy and financial stocks weighed on the S&P 500, while the Nasdaq reached a record high. In Asian markets, shares opened lower following declines in the Dow and a plunge in oil prices. It also provides short updates on various Indian companies and proposed partnerships. Technical analyses are given for two stocks, GSFC and ADANITRANS, recommending buy ranges and price targets.
The US and Asian stock markets fell this week as investors grappled with uncertainty over the upcoming US presidential election. The S&P 500 and Nasdaq saw their eighth straight day of losses on Thursday. Asian shares also slipped on Friday as anxiety rippled over the potential outcome of the US election. In India, the equity market is expected to open lower tracking declines in Asian indices. Other news mentions the GST tax rates being fixed at 5%, 12%, 18% and 28% and that the new tax structure may help reduce inflation. Several companies including Infratech, Heidelberg, Century Textiles and Dish TV are recommended for trading purposes based on technical analysis.
The document provides a market update from the US, Asian, and Indian equity markets. It discusses that US stocks rose on Tuesday as tech stocks rebounded and energy stocks increased with rising oil prices. Asian shares also rose on Wednesday rebounding from losses as Wall Street rallied. In India, the equity market is expected to open higher tracking gains in Asian indices. It also provides recommendations to buy two Indian stocks, CANBK and BHARATFORG based on technical analysis.
The document discusses several stocks and provides technical analysis and recommendations. It suggests buying Dishman Pharmaceuticals between Rs. 135-136 with a target price of Rs. 139 and stop loss of Rs. 133.50. It also recommends buying Bharti Airtel between Rs. 354-356 with a target of Rs. 363.50 and stop loss of Rs. 350.50. Asia markets opened higher on positive global cues and the Indian market is likely to react positively as well.
The document provides a morning market summary and analysis on March 9th, 2017. It discusses movements in global markets, with US markets dipping as energy stocks declined over 5% on rising inventories. Asian markets were mixed as China inflation data was released. The Indian market is expected to open lower tracking Asian indices. Two stocks, Aegischem and Marksans, are recommended as buy trades. The document also provides corporate actions, result calendar, and disclaimer.
The document provides a daily market update and analysis of specific stocks. It discusses rising costs of iron ore and coking coal affecting steel maker Kalyani Steels. It provides technical analysis of KSL and ALKEM stocks, recommending sell targets. Asian stocks opened lower following declines on Wall Street due to concerns over Deutsche Bank. Bulk deals and an earnings calendar are also included.
Dr. Reddy's Laboratories has signed a commercialization deal with Australian pharmaceutical company Hatchtech for its innovative head lice product called Xeglyze Lotion. As part of the deal, Dr. Reddy's will have exclusive rights to market the product in several territories and will pay Hatchtech upfront and milestone payments totaling up to $60 million.
Rolta India has won an additional $13 million contract to load engineering data and documents into an engineering information system it previously designed and developed for one of the world's largest petrochemical complexes.
The markets traded mixed with the Shanghai Composite down 2.21% while the Nikkei rose 1.32% ahead of the US Federal
- Vedanta's subsidiary TSPL commissioned the third 660 MW unit of its 1980 MW Talwandi Sabo thermal power plant in Punjab. TSPL had signed a PPA with Punjab State Power Corporation for establishing the 1980 MW coal-based commercial power plant.
- Dr. Reddy's launched generic versions of heart drug Nitrostat in the US market. The brand drug had US sales of around $108 million last year.
- Asian shares rebounded after doubts over the likelihood of a US Fed rate hike in September weakened the dollar. The Indian market is expected to open flat to higher tracking Asian indices.
- Vijaya Bank reported a 26% drop in net profit for the fourth quarter ended March 2016 to Rs 71.3 crore due to higher provisioning for worsening asset quality. Provisioning more than doubled to Rs 653.3 crore from Rs 305.5 crore last year.
- Glenmark Pharmaceuticals reported over a 13-fold jump in consolidated net profit to Rs 143.04 crore for the March quarter due to robust sales across all markets including the US, Europe and India. Revenue rose to Rs 2,306.67 crore from Rs 1,775.81 crore in the same period last year.
- US stocks ended mixed with gains in telecom and consumer
1) US and Asian stock markets rose as oil prices increased and Morgan Stanley's earnings boosted financial stocks. The Dow and S&P 500 gained slightly while the Nasdaq was mostly flat.
2) In Asia, stocks advanced due to strong US earnings and higher oil prices near 15-month highs as the final US presidential debate began. Indian markets are expected to open higher tracking Asian gains.
3) Several Indian companies received regulatory approvals or announced plans like acquisitions, issues of bonds, and changes to service offerings. Bulk deals and an results calendar were also included.
The document provides a technical analysis of commodity markets. It finds that gold, silver, copper, and crude oil prices are expected to decline in the near future. Gold is seen moving lower to 29500 levels, silver to 40000 levels, copper to 300 levels, and crude oil to 2975 levels. The analysis cites technical indicators like bearish candlestick patterns, prices trading below moving averages, and diverging momentum signals as reasons for the expected downward price movements. Pivot levels are also provided to identify price support and resistance levels.
FIIs and DIIs have increased their stakes in Crompton Greaves and ONGC in the September 2015 quarter compared to the June 2015 quarter. FIIs increased their stake in Crompton Greaves to 16.7% from 15.73% and DIIs increased their stake to 31.62% from 31.19%. For ONGC, FIIs reduced their stake to 6.43% from 7.23% while DIIs increased their stake to 11.05% from 10.43%. The document provides technical analysis on these stocks, recommending a buy for Crompton Greaves between 177-179 and a sell for ONGC between 263-265.
- Wall Street ended mixed on Wednesday as investors focused on President Trump's struggles to pass healthcare reform through Congress, raising concerns about his ability to enact other pro-growth policies like tax cuts.
- Asian stocks rose on Thursday following Wall Street's rebound, while the US dollar crept up from a four-month low amid ongoing uncertainty around Trump's agenda.
- The document provides recommendations to buy two Indian stocks, JKIL and SCHNEIDER, based on technical analysis showing positive trends and momentum in their share prices.
The Reserve Bank of India kept key policy rates unchanged at 7.75% in line with market expectations. While inflation has eased, the RBI is awaiting more information on the fiscal outlook and evidence that disinflation is sustainable. The RBI reduced the statutory liquidity ratio for banks to improve liquidity and provide more credit availability. India's GDP grew by 6.9% in FY14 according to revised estimates, and is projected to grow 7.4% in FY15. Industrial production growth slowed to 1.7% in December 2014, indicating weaker demand despite recent GDP growth figures.
- Aurobindo Pharma Ltd reported a 39.4% rise in Q4 net profit to Rs. 563 crore and an 18.5% increase in Q4 revenue to Rs. 3,747 crore. For the full year, net profit rose 28.5% and revenue grew 14.6%.
- Technical outlook indicates Aurobindo Pharma stock could rise further after bouncing back from support and sustaining above its 100 day moving average. The analyst recommends buying at Rs. 780-784 with a target price of Rs. 800.
- BASF India inaugurated a new construction chemicals plant in West Bengal and is expected to produce products under its Master Builders Solutions brand
This document provides an analysis on Mahindra & Mahindra (M&M) from a research analyst. It recommends buying M&M shares. Key points include:
- The Indian economy and automobile industry are improving after slowdowns, which will benefit M&M.
- M&M plans new vehicle launches and expects to regain some lost market share in utility vehicles.
- Tractor demand is expected to revive in the coming fiscal years due to various factors.
- A valuation analysis indicates M&M shares are undervalued and have 18% upside potential over the next 10-12 months.
The document provides stock recommendations and analysis for three Indian companies - Dr. Reddy's Laboratories Ltd., Ambuja Cements Ltd., and ICICI Bank Ltd. It summarizes recent price movements and trading patterns, and identifies support levels based on technical indicators. Positive factors like breakouts, moving average crossovers, and diverging momentum signals suggest further upside potential. The analyst recommends buying the stocks with provided target prices and stop losses.
Idea Cellular Ltd. Q2 FY16 Result First Cut choice broking
Idea Cellular reported quarterly results that were largely in line with estimates. Consolidated net sales were 1.7% higher than expected at Rs. 86,765.8 million, driven by higher value-added services revenue. Consolidated EBITDA of Rs. 30,526.3 million and reported PAT of Rs. 7,873.3 million also met estimates. However, key operating metrics like voice revenue, minutes of usage, and data ARPU declined sequentially, leading to a 5.3% quarter-on-quarter drop in EBITDA and 13.1% fall in reported PAT. The brokerage maintains a "Buy" rating on Idea Cellular.
This document provides an analysis on UltraTech Cement. It rates the stock as a "Buy" with a target price range of Rs. 3400-3550 over the next 12 months, representing potential upside of 14%. UltraTech is India's largest cement company and is expected to benefit from recovering economic growth and increasing cement demand in India. The company plans to aggressively expand its capacity which will help drive strong volume growth.
Sun Pharmaceutical Industries is seeking shareholder approval to raise up to Rs 12,000 crore through convertible debentures or a QIP placement to fund expansion and acquisitions. Following its merger with Ranbaxy, the company has been restructuring its business. KEC International has secured new orders worth Rs 668 crore for transmission, distribution, cables and renewable projects in India and other countries. Asian stocks traded mostly higher following gains on Wall Street, with Chinese markets leading after reopening from a weeklong holiday.
- Canara Bank reported a 15.6% decline in net profit for the second quarter due to higher provisions and weak asset quality. Net profit fell to Rs. 5.28 billion from Rs. 6.26 billion a year ago.
- Net interest income rose but provisions jumped 49% while other income dropped 18.5%. Gross bad loans rose to 4.27% from 3.98% in the previous quarter.
- Petronet LNG shares rose after RBI allowed increased foreign ownership in the company to 30% under a portfolio investment scheme.
This document summarizes the commodity call trades made in January 2016. It lists the date of each trade, commodity traded, transaction details like quantity, price targets, stop losses, and profit/loss. A total profit of Rs. 104050 was achieved over the month from trades in various commodities like lead, aluminum, zinc, nickel, crude oil, natural gas, copper, gold and silver. The highest profits came from trades in lead, silver, gold and natural gas. Some trades resulted in losses or were stopped out due to targets/stop losses being hit.
Choicebroking Currency Report: Indian Rupee rose marginally by 2 paise in Tuesday’s trading session. US IBD/ TIPP Economic Optimism rose by 2.4 points to 48.7-mark in May.
Aurobindo Pharma received approval from the US FDA to manufacture and market Tramadol Hydrochloride Extended-release Tablets, which are used to treat moderate-to-severe pain. The approved product has an estimated $56 million market size. Aurobindo now has a total of 217 ANDA approvals from the US FDA. Technically, the stock has broken out of a pennant pattern and is trading above moving averages, suggesting an upward trend. Analyst recommends buying the stock in the range of 824-828 with a target price of 845. RBI has allowed FIIs/RFPIs to invest up to 74% of Shriram Transport Finance's capital. Analyst
The Indian rupee dropped for the second day in a row against the US dollar, ending at 67.26. Sentiment in the domestic market was negative, keeping pressure on the currency. China's manufacturing PMI was unchanged at 50.1 in May. The US dollar index gained 0.4% due to increased risk aversion boosting demand for the low-yielding currency, though economic data from the US was mixed. Eurozone CPI fell 0.1% in May while unemployment remained at 10.2%.
The document provides a technical analysis of various commodities including gold, silver, copper, crude oil, and natural gas. For gold, the analysis indicates prices are expected to move lower towards 28500 levels. For silver, prices are expected to move higher towards 39250 levels. For copper, prices are expected to move higher towards 322.50 levels. For crude oil, prices are expected to move higher towards 3430 levels.
- Bank of India sold an 18% stake in its life insurance joint venture with Dai-ichi Life Insurance Company of Japan to the Japanese partner. The joint venture was formed in 2007 between Bank of India, Union Bank of India, and Dai-ichi Life Insurance to undertake life insurance business in India.
- Hindustan Unilever has decided to shut down its coffee retail chain Bru World Cafes, five years after launching it. The company confirmed it had decided to close all of its Bru World Cafe locations.
- Asian markets opened lower as investors were cautious ahead of the first presidential debate between Hillary Clinton and Donald Trump, which could impact sectors like health insurance and drugmakers.
1) The Australian Prime Minister said there is no public funding for Adani's $21.7 billion coal mine project in Australia and that he takes climate change seriously.
2) Technical analysis recommends selling Adani Enterprises between Rs. 72.05-72.5, targeting Rs. 70.
3) Mahindra & Mahindra plans to double its tractor revenue in the US and Canada to $1 billion in the next 3-4 years.
BHEL has commissioned the second 195 MW unit at the Muzaffarpur Thermal Power Station in Bihar, which is jointly owned by NTPC and BSPGCL. The first 195 MW unit was commissioned in March 2015. BHEL has over 80% market share in equipment supplied to NTPC and its joint ventures. The document also provides a technical analysis of BHEL stock, recommending buying within the range of 121-122 with a target price of 126 and stop loss of 119. It further discusses the approval of two FDI proposals amounting to Rs 2.19 crore by the Indian government.
Gayatri Projects reported a 50.9% rise in net profit to Rs. 16.14 crore for the first quarter ended June 30, 2016 compared to the same period last year. Total income from operations increased 6.75% to Rs. 432.44 crore. Other income rose 90.25% to Rs. 7.42 crore.
Tata Motors reported a 57% fall in April-June quarter profit to Rs. 2,260.4 crore due to adverse foreign exchange impact on its British arm JLR from Brexit.
Most Asian markets slipped while the US dollar held firm after Yellen indicated a US interest rate hike remains possible this year. The Indian market is expected
Lupin has increased the price of its generic diabetes drug Fortamet by three times for certain dosages. Despite the price hike, Lupin's drug is still 15% cheaper than the innovator drug. Fortamet has two generic competitors in the market - Lupin with 60% market share and Mylan, which has not yet launched its generic version. The current market size for Fortamet is estimated at $170 million. Technical analysis indicates Lupin and HCC stocks could be bought within certain price ranges. Global markets were mixed with the US closing slightly lower and Asian markets trading down due to weak Chinese economic data.
Aban Offshore has received a letter of award from ONGC for deployment of a jack-up rig for 3 years worth approximately $50 million. The contract is expected to start in Q1 2016.
Cadila Healthcare shares fell over 2% on concerns about clearance of its Moraiya facility in Gujarat by the end of the fiscal year based on a Credit Suisse downgrade and pricing impact.
US indexes finished mixed with the Dow and S&P 500 down slightly while the Nasdaq was up as traders await the Federal Reserve meeting starting Tuesday for clues on interest rates. Asian markets opened cautiously tracking Wall Street and weaker commodity prices.
Reliance Communications sold 51% of its telecom tower business to Brookfield Infrastructure for Rs 11,000 crore. The proceeds will be used to pay down debt. RCom will retain 49% stake and expects the value to increase as tower tenancies grow. The stock is recommended as a buy based on technical analysis showing support at Rs 46 and an upward trend. Life Insurance Corporation reduced its stake in Raymond by 2.01% by selling shares, bringing its holding down to 5.53%. The stock is recommended as a sell based on decreasing volume and a spinning top candlestick indicating weakness. Asian shares dipped after comments from Janet Yellen boosted US bond yields, while Chinese inflation data is expected this week.
The document provides a daily market summary and analysis from an Indian stock brokerage firm. It discusses the performance of key global markets, including a small gain in the US and flat trading in Asia. It also notes several domestic Indian news stories and provides technical analysis on two Indian stocks, recommending buy signals. The summary focuses on the key market updates and trading recommendations.
The document summarizes key developments in global and Asian stock markets as well as the expected opening of the Indian market. It notes that major US stock indexes hit record highs after comments from Janet Yellen supporting an interest rate hike in March. In Asia, stock indexes rose following gains on Wall Street. The Indian market is expected to open flat to positive tracking Asian markets. The document also provides commentary and recommendations on specific Indian stocks.
- Local search engine Just Dial received in-principle approval from RBI to launch a prepaid wallet, allowing it to provide payment solutions to users as part of its transaction services. Just Dial needs to submit additional reports to RBI by March 5, 2017 for final authorization.
- Technical analysis indicates Just Dial stock has formed a hammer candlestick pattern near the bottom, suggesting a trend reversal. The stock is recommended as a buy between Rs. 497-500 with a target price of Rs. 510 and stop loss of Rs. 492.
- Jindal Steel reported a widening of consolidated net loss for the April-June quarter compared to the same period last year, while net sales also
- Havells India reported a 22% rise in net profit for the second quarter ended September 30, 2016 to Rs. 145.79 crore compared to Rs. 119.53 crore during the same period last year. Total income grew 9.8% to Rs. 1,584.63 crore.
- Marksans Pharma received US FDA approval for Paricalcitol capsules used to treat hyperparathyroidism.
- Asian shares edged up after Wall Street gained on encouraging corporate earnings and optimism about upcoming Chinese economic data. The Indian market is expected to open gap up tracking Asian indices.
Reliance Capital aims to more than double its customer base to 50 million over the next 3-5 years. The company currently has a customer base of 20 million across insurance, mutual funds, brokerage and other financial services. In Q1 FY2015-16, Reliance Capital reported total income of Rs. 9,998 crore, up 12% year-over-year, while net profit stood at Rs. 1,101 crore, up 10% year-over-year. Technical indicators show the stock is in an uptrend and analysts recommend buying the stock between Rs. 542-545 for a target of Rs. 555 with a stop loss of Rs. 537.
- The document provides technical analysis on two stocks - Godrej Consumer Products Ltd. (GCPL) and TVS Motor Company. It recommends buying GCPL between Rs. 1214-1223 with a target of Rs. 1248 and stop loss of Rs. 1201 and buying TVS Motor between Rs. 233-235 with a target of Rs. 242 and stop loss of Rs. 229.
- It also provides updates on global markets, key Indian indices and upcoming corporate actions and results calendar. US stocks rose on Friday while Asian markets opened mixed on Monday as traders await the US Federal Reserve meeting this week.
Jindal Steel & Power has sold its 24MW wind power business in Maharashtra for approximately Rs. 20.86 crore. This sale represents about 0.14% of Jindal Steel's standalone turnover from last fiscal year. The net worth of the business was approximately Rs. 112 crore or 0.98% of Jindal Steel's standalone net worth for the same period.
Shilpa Medicare received US FDA approval to sell its Azacitidine injection in the US. The drug is used to treat myelodysplastic syndrome.
Asian shares were mixed in early trading as investors weighed the potential for a Deutsche Bank settlement and a US interest rate hike against Japanese stock gains.
The document provides a market summary and analysis from an Indian stock brokerage firm. It summarizes that US stocks edged higher on positive outlook from UnitedHealth, while energy shares fell on lower oil prices. Asian markets opened positively after OPEC reached an oil production cut deal. The Indian market is expected to open flat tracking Asian indices. It provides technical analysis on two Indian stocks, recommending buying ranges and price targets.
The US Federal Reserve raised interest rates by 0.25% and signaled that further hikes may come faster than expected in 2017, which caused US stocks to fall sharply. Asian markets also struggled in response. The Indian market is expected to open lower, tracking losses in Asian indices. Two stocks, UPL and GMDC, are recommended as short sell opportunities based on technical analysis showing bearish patterns and indicators.
#ChoiceBroking #MorningTea - Global View: US stocks were modestly lower on Thursday, weighed down by a drop in healthcare and consumer names, while financials advanced
slightly after two more Federal Reserve officials pushed the case for a rate hike.
- Mahindra & Mahindra reported a 5% fall in auto sales for September 2015 compared to the same period last year. Domestic sales fell 7.46% while exports grew 26%.
- Suven Life Sciences secured three new patents related to treatments for neurodegenerative disorders, bringing their total patents to 24 in New Zealand and 22 each in Singapore and the US.
- Technical indicators suggest selling M&M around 1250-1258 levels with a target of 1225 and stop loss of 1271, and buying Suven around 284-286 levels with a target of 292 and stop loss of 281.
The document provides a daily market summary and analysis from an Indian brokerage firm. It discusses movements in the US, Asian, and Indian markets. The US Fed raised interest rates and hinted at three more hikes in 2017. Asian stocks were mixed in response to higher US rates. In India, specific stocks like Maruti Suzuki, Cipla, and Wipro were discussed. Technical analysis was provided for Hindustan Zinc and Titan, recommending buy and sell signals respectively based on chart patterns and indicators. Upcoming corporate actions and bulk deals were also summarized.
Discover the Future of Dogecoin with Our Comprehensive Guidance36 Crypto
Learn in-depth about Dogecoin's trajectory and stay informed with 36crypto's essential and up-to-date information about the crypto space.
Our presentation delves into Dogecoin's potential future, exploring whether it's destined to skyrocket to the moon or face a downward spiral. In addition, it highlights invaluable insights. Don't miss out on this opportunity to enhance your crypto understanding!
https://36crypto.com/the-future-of-dogecoin-how-high-can-this-cryptocurrency-reach/
[4:55 p.m.] Bryan Oates
OJPs are becoming a critical resource for policy-makers and researchers who study the labour market. LMIC continues to work with Vicinity Jobs’ data on OJPs, which can be explored in our Canadian Job Trends Dashboard. Valuable insights have been gained through our analysis of OJP data, including LMIC research lead
Suzanne Spiteri’s recent report on improving the quality and accessibility of job postings to reduce employment barriers for neurodivergent people.
Decoding job postings: Improving accessibility for neurodivergent job seekers
Improving the quality and accessibility of job postings is one way to reduce employment barriers for neurodivergent people.
Economic Risk Factor Update: June 2024 [SlideShare]Commonwealth
May’s reports showed signs of continued economic growth, said Sam Millette, director, fixed income, in his latest Economic Risk Factor Update.
For more market updates, subscribe to The Independent Market Observer at https://blog.commonwealth.com/independent-market-observer.
Optimizing Net Interest Margin (NIM) in the Financial Sector (With Examples).pdfshruti1menon2
NIM is calculated as the difference between interest income earned and interest expenses paid, divided by interest-earning assets.
Importance: NIM serves as a critical measure of a financial institution's profitability and operational efficiency. It reflects how effectively the institution is utilizing its interest-earning assets to generate income while managing interest costs.
OJP data from firms like Vicinity Jobs have emerged as a complement to traditional sources of labour demand data, such as the Job Vacancy and Wages Survey (JVWS). Ibrahim Abuallail, PhD Candidate, University of Ottawa, presented research relating to bias in OJPs and a proposed approach to effectively adjust OJP data to complement existing official data (such as from the JVWS) and improve the measurement of labour demand.
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby...Donc Test
Solution Manual For Financial Accounting, 8th Canadian Edition 2024, by Libby, Hodge, Verified Chapters 1 - 13, Complete Newest Version Solution Manual For Financial Accounting, 8th Canadian Edition by Libby, Hodge, Verified Chapters 1 - 13, Complete Newest Version Solution Manual For Financial Accounting 8th Canadian Edition Pdf Chapters Download Stuvia Solution Manual For Financial Accounting 8th Canadian Edition Ebook Download Stuvia Solution Manual For Financial Accounting 8th Canadian Edition Pdf Solution Manual For Financial Accounting 8th Canadian Edition Pdf Download Stuvia Financial Accounting 8th Canadian Edition Pdf Chapters Download Stuvia Financial Accounting 8th Canadian Edition Ebook Download Stuvia Financial Accounting 8th Canadian Edition Pdf Financial Accounting 8th Canadian Edition Pdf Download Stuvia
The Universal Account Number (UAN) by EPFO centralizes multiple PF accounts, simplifying management for Indian employees. It streamlines PF transfers, withdrawals, and KYC updates, providing transparency and reducing employer dependency. Despite challenges like digital literacy and internet access, UAN is vital for financial empowerment and efficient provident fund management in today's digital age.
"Does Foreign Direct Investment Negatively Affect Preservation of Culture in the Global South? Case Studies in Thailand and Cambodia."
Do elements of globalization, such as Foreign Direct Investment (FDI), negatively affect the ability of countries in the Global South to preserve their culture? This research aims to answer this question by employing a cross-sectional comparative case study analysis utilizing methods of difference. Thailand and Cambodia are compared as they are in the same region and have a similar culture. The metric of difference between Thailand and Cambodia is their ability to preserve their culture. This ability is operationalized by their respective attitudes towards FDI; Thailand imposes stringent regulations and limitations on FDI while Cambodia does not hesitate to accept most FDI and imposes fewer limitations. The evidence from this study suggests that FDI from globally influential countries with high gross domestic products (GDPs) (e.g. China, U.S.) challenges the ability of countries with lower GDPs (e.g. Cambodia) to protect their culture. Furthermore, the ability, or lack thereof, of the receiving countries to protect their culture is amplified by the existence and implementation of restrictive FDI policies imposed by their governments.
My study abroad in Bali, Indonesia, inspired this research topic as I noticed how globalization is changing the culture of its people. I learned their language and way of life which helped me understand the beauty and importance of cultural preservation. I believe we could all benefit from learning new perspectives as they could help us ideate solutions to contemporary issues and empathize with others.
Abhay Bhutada, the Managing Director of Poonawalla Fincorp Limited, is an accomplished leader with over 15 years of experience in commercial and retail lending. A Qualified Chartered Accountant, he has been pivotal in leveraging technology to enhance financial services. Starting his career at Bank of India, he later founded TAB Capital Limited and co-founded Poonawalla Finance Private Limited, emphasizing digital lending. Under his leadership, Poonawalla Fincorp achieved a 'AAA' credit rating, integrating acquisitions and emphasizing corporate governance. Actively involved in industry forums and CSR initiatives, Abhay has been recognized with awards like "Young Entrepreneur of India 2017" and "40 under 40 Most Influential Leader for 2020-21." Personally, he values mindfulness, enjoys gardening, yoga, and sees every day as an opportunity for growth and improvement.
How Does CRISIL Evaluate Lenders in India for Credit RatingsShaheen Kumar
CRISIL evaluates lenders in India by analyzing financial performance, loan portfolio quality, risk management practices, capital adequacy, market position, and adherence to regulatory requirements. This comprehensive assessment ensures a thorough evaluation of creditworthiness and financial strength. Each criterion is meticulously examined to provide credible and reliable ratings.
Detailed power point presentation on compound interest and how it is calculated
Morning tea 19 01-2016
1. SEBI Certified – Research Analyst www.choiceindia.com
Global View
India Update
Today’s Event/ Stock in News
Sectorspecificnews:Lowercrudeoilpriceswouldresultinlowerrealizationfromcrudesalesforoilexplorationfirms.Brentcrudeoil
futures slumped after international sanctions on Iran were lifted, adding to the global supply glut. Brent for March settlement
currently down 22 cents a barrel at $28.72 a barrel. The contract had slumped $1.94 a barrel or 6.28% to settle at $28.94 a barrel
duringtheprevioustradingsession.
Technical Outlook: Consistent drawdown in Oil prices has direct repercussion on oil producing company. As growth engine is
slowingdowntherewillbelessdemandforOil.FromTechnicalperspective,it isalreadyoperatingat 52weeklowandatthisplaceit
had broken its ascending triangle on down side which is bearish continuation pattern. As concern for oil prices is going on, one can
seepressureinstockincomingtradingsession.
OIL
BHEL
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
Morning Tea
19th Jan 2016
Buy in the range of 142-140 for the Target of 148 with the SL of 138
Sell in the range of 347-350 for the Target of 342 with the SL of 351
State-run Bharat Heavy Electricals Ltd (BHEL) on Monday said it has commissioned 660 MW supercritical unit of Lalitpur Super
Thermal Power Project (STPP). This is the second 660 MW unit commissioned by the company in UP.“BHEL commissions second
660 MW supercritical thermal unit in Uttar Pradesh within a fortnight,” BHEL said in a filing to the Bombay Stock Exchange on
January 18, 2016. BHEL has successfully commissioned the first unit of 3x660 MW Prayagraj Super Thermal Power Project (STPP) at
Bara in Allahabad district of UP, it added. The unit has been synchronised by BHEL four months ahead of the schedule agreed with
thedeveloper,itsaid..
Technical Outlook: BHEL had reduced down to its earlier support point at 131 level where it had taken support earlier. To validate
support it had formed piercing candle. It indicates there is small attempt of bulls to make their presence felt. From location point of
view,ithadtakensupportatkeysupportpoint.BHEListradingin oversoldregion,somildbouncebackisexpected.
Wall Asian stocks were subdued early on Tuesday following a retreat in European shares overnight, while crude oil prices remained bearish
following the lifting of sanctions against major producer Iran. Asia had no leads from Wall Street as the U.S. markets were closed on Monday for
Martin Luther King Day. MSCI's broadest index of Asia-Pacific shares outside Japan .MIAPJ0000PUS dipped 0.1 percent, touching its lowest since
2011. Tokyo's Nikkei shed 0.3percent. Thepan-EuropeanFTSEurofirst 300 index, which haslost more than10 percent thisyear,dropped afurther
0.3percenton Monday,withanindexofeurozonebanksdown3.4percent.EuropeanbanksharestookahitaftertheEuropeanCentralBanksaid
itwouldquizeurozonelendersabouthighlevelsofbadloans.
TheindicatorTheIndianNiftyislikelytoopeninthegreenonTuesdayasindicatedbythepositivetrendin SGXNifty,whichwastradingat7,393,up
34pointsat7:48AM.AsianmarketsweretradingflatasChinareleaseditsfourth quarterGDPdataat6.8percent,marginallylowerthanexpected,
compared to 7.3 percent last year. Shanghai was up 0.4 percent while Nikkei was up about 0.3 percent. In commodities, crude prices remained
nearmulti-yearlowsasIrangearsuptopump5lakhbarrelsperday.Brentcrudetradedaround28dollarsperbarrel.TheUSDgainedsomeground
againsttheeurowhilegoldpricesremainedsteadyataround1090 dollarsanounceasoilslumped.
2. SEBI Certified – Research Analyst www.choiceindia.com
Bulk Deal
Corporate Action / Result Calendar
SEBI Certified – Research Analyst www.choiceindia.com
Morning Tea
Corporate Action:
Result Calendar:
DEEPIND,EASTRED,GREENPLY,HCLTECH, JINDHOT, MAHAVIRIND, OPCHAINS, PAUSHAKLTD,
RELIANCE, RPOWER, TRITURBINE, ZENSARTECH
19th Jan 2016
Security in Ban
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website
BANKINDIA, DLF, IDBI, INDIACEM, JINDALSTEL, JISLJALEQS, UNITECH, WOCKPHARMA
Sr. No. Deal Date Script Code Security Name Client Name Deal Type Quantity Price
1 15/01/2016 532622 GDL GMO EMERGING DOMESTIC OPPORTUNITIES FU B 732174 343.00
2 15/01/2016 532931 BURNPUR WHITE COLLAR VENTURE CAPITAL FUND LIMITE B 535000 10.83
3 15/01/2016 517467 MARSONS ADVANCE POWERINFRA TECH LIMITED S 250000 10.06
4 15/01/2016 517467 MARSONS TIKRI INVESTMENTS B 221767 10.06
5 15/01/2016 500284 LORDSCHLO RAJENDER KUMAR JAIN (HUF) S 160151 27.57
6 15/01/2016 500284 LORDSCHLO ALISHA JAIN B 130135 27.56
7 15/01/2016 539526 SCTL ZAVERI & CO EXPORTS B 106000 63.89
8 15/01/2016 502761 BLUBLND-B EARC TRUST SC 03 S 101407 79.38
9 15/01/2016 530871 CHEMBOND VINOD D SHAH B 46600 435.00
10 15/01/2016 530871 CHEMBOND BINA A SHETH S 46400 435.00
3. SEBI Certified – Research Analyst www.choiceindia.com
Contact Us
www.choiceindia.com
www.choiceindia.comcustomercare@choiceindia.com
Disclaimer
This is solely for information of clients of Choice Broking and does not construe to be an investment advice. It is also not intended as an offer or solicitation for the purchase and sale of any financial
instruments. Any action taken by you on the basis of the information contained herein is your responsibility alone and Choice Broking its subsidiaries or its employees or associates will not be liable in
any manner for the consequences of such action taken by you. We have exercised due diligence in checking the correctness and authenticity of the information contained in this recommendation, but
Choice Broking or any of its subsidiaries or associates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the
information contained in this recommendation or any action taken on basis of this information. Technical analysis studies market psychology, price patterns and volume levels. It is used to forecast
future price and market movements. Technical analysis is complementary to fundamental analysis and news sources. The recommendations issued herewith might be contrary to recommendations
issued by Choice Broking in the company research undertaken as the recommendations stated in this report is derived purely from technical analysis. Choice Broking has based this document on
information obtained from sources it believes to be reliable but which it has not independently verified; Choice Broking makes no guarantee, representation or warranty and accepts no responsibility
or liability as to its accuracy or completeness. The opinions contained within the report are based upon publicly available information at the time of publication and are subject to change without
notice. The information and any disclosures provided herein are in summary form and have been prepared for informational purposes. The recommendations and suggested price levels are intended
purely for trading purposes. The recommendations are valid for the day of the report however trading trends and volumes might vary substantially on an intraday basis and the recommendations may
be subject to change. The information and any disclosures provided herein may be considered confidential. Any use, distribution, modification, copying, forwarding or disclosure by any person is
strictly prohibited. The information and any disclosures provided herein do not constitute a solicitation or offer to purchase or sell any security or other financial product or instrument. The current
performance may be unaudited. Past performance does not guarantee future returns. There can be no assurance that investments will achieve any targeted rates of return, and there is no guarantee
against the loss of your entire investment.
POTENTIAL CONFLICT OF INTEREST DISCLOSURE (as on date of report) Disclosure of interest statement – • Analyst interest of the stock /Instrument(s): - No. • Firm interest of the stock /
Instrument (s): - No.
SEBI Certified – Research Analyst www.choiceindia.com
Research Team
Mr. Sumeet Bagadia Associate Director
Kunal Parmar Research Associate
Amit Pathania Research Associate
Vikas Chaudhari Research Associate
Kapil Shah Research Associate
Rajnath Yadav Research Associate
Satish Kumar Research Associate
Morning Tea
19th Jan 2016
SEBI Registered – Research Analyst www.choiceindia.com * Please Refer Disclaimer on Website